FAQ
This page presents clinical evidence and real-world case outcomes for CholeDerm® and other products developed with Alicorn Medical's PrisTINE Technology.
Clinical evidence shows CholeDerm® accelerates wound healing, reduces complications, and improves patient outcomes, based on clinical trials and real-world applications.
Yes. The page includes a Clinical Compendium featuring real case reports, including a documented case of CholeDerm® used for implant exposure and osteoradionecrosis, treated by Dr. Anoop Attakkil, Surgical Oncologist at Malabar Cancer Centre.
PrisTINE Technology is Alicorn Medical's proprietary manufacturing process that uses no enzymes and no detergents, preserving the natural architecture of the extracellular matrix (ECM) for faster wound healing.
Clinical evidence is contributed by treating physicians and surgical specialists across hospitals in India who use CholeDerm® in real-world patient care.
Yes. Alicorn Medical states that it continues to refine its offerings through ongoing clinical trials and real-world applications to ensure optimal patient care.